Radiopaque enhanced cobalt alloy for stents

US11141296B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11141296-B2
Application numberUS-201715421632-A
CountryUS
Kind codeB2
Filing dateFeb 1, 2017
Priority dateApr 26, 2012
Publication dateOct 12, 2021
Grant dateOct 12, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A stent is formed of at least a cobalt-based alloy. The cobalt-based alloy may include 10-35 weight % metal member selected from the group consisting of platinum (Pt), gold (Au), iridium (Ir), osmium (Os), rhenium (Re), tungsten (W), palladium (Pd), tantalum (Ta), and combinations thereof; 16-21 weight % chromium (Cr); 9-12 weight % molybdenum (Mo); 0-25 weight % nickel (Ni); and balance cobalt (Co). The cobalt-based alloy may be a thin outer shell of a hollow stent. The cobalt-based alloy may be used to form at least one of an inner core and an outer shell of a core-shell structure of a stent. The cobalt-based alloy may be used to form an end of a wire for forming a stent.

First claim

Opening claim text (preview).

What is claimed is: 1. A stent comprising: a cobalt-based alloy, wherein the cobalt-based alloy is free of molybdenum (Mo), the cobalt based alloy comprising about 14 weight % tungsten (W) and 10-14 weight % platinum (Pt); 20-24 weight % chromium (Cr); 8-12 weight % nickel (Ni); 0-3 weight % iron (Fe); and balance cobalt (Co). 2. The stent of claim 1 , wherein the cobalt-based alloy is free of molybdenum (Mo) and is formed of: about 14 weight % tungsten (W) and 10-14 weight % platinum (Pt); about 22 weight % chromium (Cr); 8-12 weight % nickel (Ni) 0-0.15 weight % carbon (C); 0-3 weight % iron (Fe); about 1.5 weight % manganese (Mn); 0-1.0 weight % silicon (Si); 0-0.03 weight % lanthanum (La); and balance cobalt (Co). 3. A stent comprising: a plurality of struts formed by a wire, the wire comprising an outer shell substantially surrounding an inner core, wherein one of the outer shell and the inner core comprises a cobalt-based alloy and the other of the outer shell and the inner core comprises a metal member selected from the group consisting of platinum (Pt), gold (Au), iridium (Ir), osmium (Os), rhenium (Re), tungsten (W), palladium (Pd), tantalum (Ta), and combinations thereof, the cobalt-based alloy comprising: 10-35 weight % the metal member; 16-21 weight % chromium (Cr); 9-12 weight % molybdenum (Mo); 10-18 weight % nickel (Ni); 0-3 weight % iron (Fe); and balance cobalt (Co). 4. The stent of claim 3 , wherein the metal member of the cobalt-based alloy and the metal member of the other of the outer shall and the inner core comprises about 20% to and 45% by weight of the total wire comprising the outer shell and the inner core. 5. The stent of claim 3 , wherein the cobalt-chromium alloy comprises about 1 weight % iron (Fe). 6. A stent comprising: a cobalt-based alloy comprising 10-35 weight % metal member selected from the group consisting of platinum (Pt), gold (Au), iridium (Ir), osmium (Os), rhenium (Re), tungsten (W), palladium (Pd), tantalum (Ta), and combinations thereof; 16-21 weight % chromium (Cr); 9-12 weight % molybdenum (Mo); 10-18 weight % nickel (Ni); 0-3 weight % iron (Fe); and balance cobalt (Co). 7. The stent of claim 6 , wherein the cobalt-chromium alloy comprises about 1 weight % iron (Fe). 8. The stent of claim 6 , wherein the cobalt-based alloy further comprises one or more of 0-0.015 weight % boron (B); 0-0.15 weight % carbon (C); 0-1.5 weight % manganese (Mn); 0-0.04 weight % phosphorous (P); 0-1.0 weight % silicon (Si); 0-1 weight % titanium (Ti); and 0-0.03 weight % sulfur (S). 9. The stent of claim 6 , wherein the cobalt-based alloy further comprises one or more of about 0.010 weight % boron (B); 0-0.025 weight % carbon (C); 0-1.0 weight % iron (Fe); 0-0.15 weight % manganese (Mn); 0-0.015 weight % phosphorous (P); 0-0.15 weight % silicon (Si); 0-0.01 weight % sulfur (S); and 0-1 weight % titanium (Ti).

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11141296B2 cover?
A stent is formed of at least a cobalt-based alloy. The cobalt-based alloy may include 10-35 weight % metal member selected from the group consisting of platinum (Pt), gold (Au), iridium (Ir), osmium (Os), rhenium (Re), tungsten (W), palladium (Pd), tantalum (Ta), and combinations thereof; 16-21 weight % chromium (Cr); 9-12 weight % molybdenum (Mo); 0-25 weight % nickel (Ni); and balance cobalt…
Who is the assignee on this patent?
Medtronic Vascular Inc
What technology area does this patent fall under?
Primary CPC classification A61L31/022. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).